Conference abstractPublished 7 May 2018
Iranandprime;s pharmaceutical industry: Structure, players and institutions and regulatory system
Islamic Azad University, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The present research seeks to understand the behavioral logic of the players of Iran's pharmaceutical industry so as to infer the innovative treatment of the firms. The structure of such an approach is composed of some components through which performance analysis of certain technological industry could be made possible. In this research, we use two steps of expert panel review: first step is 17 experts and second step is 11 experts from universities, companies and governmental institutes. The current study wishes to explain structural model of institutional elements in this technological sector. Subsequently, in light of such an explanation, structural elements of this sector would be analyzed through identification of legal and regulatory framework, innovative culture, innovative infrastructure, financial resources, information resources, technology transfer mechanisms, commercialization support and marketing.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bahman Kargar Shahamat”
